Keith E. Suckling

4.9k total citations · 2 hit papers
123 papers, 4.1k citations indexed

About

Keith E. Suckling is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Keith E. Suckling has authored 123 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Surgery, 46 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Keith E. Suckling's work include Cholesterol and Lipid Metabolism (45 papers), Lipoproteins and Cardiovascular Health (31 papers) and Drug Transport and Resistance Mechanisms (21 papers). Keith E. Suckling is often cited by papers focused on Cholesterol and Lipid Metabolism (45 papers), Lipoproteins and Cardiovascular Health (31 papers) and Drug Transport and Resistance Mechanisms (21 papers). Keith E. Suckling collaborates with scholars based in United Kingdom, United States and Canada. Keith E. Suckling's co-authors include Eduard F. Stange, Colin H. Macphee, Muriel Caslake, Chris J. Packard, Lisa Patel, Brian Jackson, George S. Boyd, Kathleen M. Botham, G.S. Boyd and John M. Dietschy and has published in prestigious journals such as New England Journal of Medicine, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

Keith E. Suckling

122 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease

2000 671 citations Chris J. Packard, D S O’Reilly et al. New England Journal of Medicine profile →
Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.

1985 481 citations Keith E. Suckling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith E. Suckling United Kingdom	29	2.1k	1.6k	779	731	724	123	4.1k
R C Pittman United States	25	2.1k 1.0×	1.3k 0.8×	781 1.0×	1.1k 1.6×	399 0.6×	32	3.8k
P. Haydn Pritchard Canada	38	1.9k 0.9×	1.5k 1.0×	645 0.8×	1.2k 1.7×	433 0.6×	111	4.3k
Narendra D. Lalwani United States	30	1.4k 0.7×	2.2k 1.4×	788 1.0×	620 0.8×	381 0.5×	65	4.1k
Jane M. Glick United States	39	2.0k 1.0×	1.9k 1.2×	659 0.8×	1.4k 1.9×	569 0.8×	84	4.5k
E L Bierman United States	32	2.0k 0.9×	1.5k 1.0×	794 1.0×	1.6k 2.2×	566 0.8×	76	4.4k
Noel Fidge Australia	38	2.1k 1.0×	1.5k 1.0×	915 1.2×	1.9k 2.6×	463 0.6×	120	4.1k
A D Cooper United States	32	1.3k 0.6×	921 0.6×	488 0.6×	776 1.1×	433 0.6×	46	2.6k
Pieter H.E. Groot Netherlands	38	1.6k 0.7×	1.8k 1.1×	756 1.0×	1.2k 1.6×	754 1.0×	91	5.1k
P E Fielding United States	28	2.5k 1.2×	1.7k 1.1×	977 1.3×	1.8k 2.5×	376 0.5×	38	4.4k
Philippe Costet France	32	3.2k 1.5×	2.1k 1.3×	644 0.8×	631 0.9×	437 0.6×	45	4.5k

Countries citing papers authored by Keith E. Suckling

Since Specialization

Citations

This map shows the geographic impact of Keith E. Suckling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith E. Suckling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith E. Suckling more than expected).

Fields of papers citing papers by Keith E. Suckling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith E. Suckling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith E. Suckling. The network helps show where Keith E. Suckling may publish in the future.

Co-authorship network of co-authors of Keith E. Suckling

This figure shows the co-authorship network connecting the top 25 collaborators of Keith E. Suckling. A scholar is included among the top collaborators of Keith E. Suckling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith E. Suckling. Keith E. Suckling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suckling, Keith E.. (2012). The landscape of drug discovery in atherosclerosis and dyslipidaemia revisited: an update of patenting activity. Expert Opinion on Therapeutic Patents. 22(3). 199–204. 1 indexed citations

Roos, Baukje de, Muriel Caslake, Kevin J. Milliner, et al.. (2005). Characterisation of the lipoprotein structure in the St. Thomas’ Mixed Hyperlipidaemic (SMHL) rabbit. Atherosclerosis. 181(1). 63–68. 4 indexed citations

Moore, Elizabeth Hernández, Mariarosaria Napolitano, Michael Avella, et al.. (2004). Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells. European Journal of Biochemistry. 271(12). 2417–2427. 19 indexed citations

Hockings, Paul, Graham J. Galloway, David G. Reid, et al.. (2002). Repeated Three-Dimensional Magnetic Resonance Imaging of Atherosclerosis Development in Innominate Arteries of Low-Density Lipoprotein Receptor-Knockout Mice. Circulation. 106(13). 1716–1721. 43 indexed citations

Macphee, Colin H. & Keith E. Suckling. (2002). Lipoprotein-associated phospholipase A₂: a target directed at the atherosclerotic plaque. Expert Opinion on Therapeutic Targets. 6(3). 309–314. 29 indexed citations

Packard, Chris J., D S O’Reilly, Muriel Caslake, et al.. (2000). Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease. New England Journal of Medicine. 343(16). 1148–1155. 671 indexed citations breakdown →

Berkhout, Theo A., Dilip D. Patel, C. Bentzen, et al.. (1996). The Novel Cholesterol-lowering Drug SR-12813 Inhibits Cholesterol Synthesis via an Increased Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase. Journal of Biological Chemistry. 271(24). 14376–14382. 35 indexed citations

Harte, Rachel, Stephen J. Yeaman, J. McElhinney, et al.. (1996). Effects of novel synthetic sterol probes on enzymes of cholesterol metabolism in cell-free and cellular systems. Chemistry and Physics of Lipids. 83(1). 45–59. 12 indexed citations

Suckling, Keith E., et al.. (1994). Novel agents in the treatment of atherosclerosis. Expert Opinion on Investigational Drugs. 3(5). 481–491. 1 indexed citations

10.

Suckling, Keith E.. (1994). Patent Update: Cardiovascular & Renal: Approaches to anti-atherosclerotic drugs independent of lipid lowering. Expert Opinion on Therapeutic Patents. 4(11). 1371–1375. 1 indexed citations

11.

Suckling, Keith E., William Kerns, Andrew Gee, et al.. (1994). SK&F 99085/SR-9223i, a novel hypocholesterolemic agent with multiple anti-atherosclerotic properties, lowers plasma cholesterol in normocholesterolemic animals. Atherosclerosis. 109(1-2). 166–167. 2 indexed citations

12.

Suckling, Keith E.. (1993). Emerging strategies for the treatment of atherosclerosis as seen from the patent literature. Biochemical Society Transactions. 21(3). 660–662. 3 indexed citations

13.

Benson, G. Martin, David R. Alston, Brian Bond, et al.. (1993). SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster. Atherosclerosis. 101(1). 51–60. 17 indexed citations

14.

Suckling, Keith E., G. Martin Benson, Brian Bond, et al.. (1991). Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment. Atherosclerosis. 89(2-3). 183–190. 109 indexed citations

15.

Groenewegen, W. Antoinette, et al.. (1990). cDNA and deduced amino acid sequence of a novel cytochrome P-450 from female rat liver mRNA with high homology to P-450 IIC family. Nucleic Acids Research. 18(23). 7156–7156. 9 indexed citations

16.

Ochoa, Begoña & Keith E. Suckling. (1987). Short-term metabolism of cholesteryl ester from low-density lipoprotein in primary monolayers of bovine adrenal cortical cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 918(2). 159–167. 6 indexed citations

17.

Agutter, Paul S. & Keith E. Suckling. (1982). The fluidity of the nuclear envelope lipid does not affect the rate of nucleocytoplasmic RNA transport in mammalian liver. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 696(3). 308–314. 13 indexed citations

18.

Suckling, Keith E., et al.. (1979). The importance of the phospholipid bilayer and the length of the cholesterol molecule in membrane structure. Biochimica et Biophysica Acta (BBA) - Biomembranes. 551(1). 10–21. 41 indexed citations

19.

Agutter, Paul S., et al.. (1979). Modification in vitro of Cholesterol Content of Sheep Liver Nuclear Envelope. Biochemical Society Transactions. 7(5). 926–927. 1 indexed citations

20.

Boyd, G.S., et al.. (1974). Studies on the specificity of the rat liver microsomal cholesterol 7α-hydroxylase. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 337(1). 132–135. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact